Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world studyEmanuele Cerulli Irelli, Antonietta Coppola, Katarzyna Maria Mieszczanek et al.|Epilepsia|2025Cited by 15
Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiologySimona Balestrini, Ilaria Camilla Galli, Elena Parrini et al.|Epilepsia|2025Cited by 3
Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsyEmanuele Cerulli Irelli, Antonietta Coppola, Adolfo Mazzeo et al.|Epilepsy & Behavior|2026Cited by 0
Real-world effectiveness and tolerability of highly purified cannabidiol in patients with monogenic developmental and epileptic encephalopathies with highly active epilepsyEmanuele Cerulli Irelli, et al, Adolfo Mazzeo et al.|Universität Zürich, ZORA|2026Cited by 0